Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,104 public trials 536 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Completed

SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

NCT01752933

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 24 locations
View Trial Details
Completed

Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

NCT02112656

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Toronto General Hospital Toronto, Ontario, Canada
  • Mengchao Hepatobiliary Hospital of Fujian Medicatl University Fuzhou, Fujian, China
  • Xijing Hospital Xi'an, Shaanxi, China
View all 61 locations
View Trial Details
Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

NCT02509507

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of California Los Angeles Santa Monica, California, United States
  • Georgetown-Howard University Center for Clinical Translational Science Washington D.C., District of Columbia, United States
  • University of Louisville James Graham Brown Cancer Center Louisville, Kentucky, United States
View all 32 locations
View Trial Details

Related conditions